Hyperice v. Arboleaf: Massage Gun Patent Dispute Resolved in 174 Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Hyper Ice, Inc. v. Arboleaf Corporation |
| Case Number | 2:24-cv-00066 |
| Court | Eastern District of Texas |
| Duration | Feb 1, 2024 – Jul 24, 2024 174 days |
| Outcome | Dismissed with prejudice — Private Resolution |
| Patents at Issue | |
| Accused Products | Arboleaf’s CM20C, CM40A, J2 percussive massage devices, and Mini Massage Gun |
Case Overview
The Parties
⚖️ Plaintiff
Leading manufacturer of percussive therapy and recovery technology products. Co-plaintiff Hyperice IP Subco, LLC is an IP holding entity.
🛡️ Defendant
Consumer electronics company marketing massage therapy and wellness devices, including the accused CM20C, CM40A, J2, and Mini Massage Guns.
The Patent at Issue
This litigation centered on **U.S. Patent No. 11,857,482** (application number US17/681367), which covers innovations in percussive massage device technology. While specific claim language was not disclosed in available case records, percussive therapy device patents typically protect amplitude control, attachment mechanisms, motor architecture, force delivery systems, and ergonomic configurations — all commercially significant features in the competitive massage gun market.
- • US 11,857,482 — Innovations in percussive massage device technology
Developing a percussive therapy product?
Check if your device design or features might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
On July 24, 2024, the court granted the parties’ **Joint Motion to Dismiss** (Dkt. No. 31), dismissing all claims and causes of action between Hyper Ice, Inc., Hyperice IP Subco, LLC, and Arboleaf Corporation **with prejudice**. Each party was ordered to bear its own costs, expenses, and attorneys’ fees. This swift resolution in just 174 days suggests a privately negotiated settlement or licensing agreement, with no damages award or injunctive relief entered by the court.
Key Legal Issues
The Eastern District of Texas remains a plaintiff-favorable venue, and its case management timelines often encourage early settlement. The dismissal ‘with prejudice’ means Hyperice cannot re-file the same claims against Arboleaf for these products. This strategic outcome indicates an efficient resolution for Hyperice, potentially involving a licensing deal, and a cost-effective exit for Arboleaf before extensive litigation.
Freedom to Operate (FTO) Analysis for Percussive Devices
This case highlights critical IP risks in the rapidly growing percussive massage device market. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in percussive therapy patents
- Understand claim construction patterns (if revealed in lead case)
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own percussive massage device.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Percussive massage device technology
1 Patent at Issue
In percussive therapy space
Design-Around Options
Available for most claims
✅ Key Takeaways
Eastern District of Texas remains a preferred venue for patent holders asserting consumer device patents; expect continued filings here.
Search related case law →Multi-defendant, multi-case consolidated structures (lead case + member cases) are a sophisticated assertion architecture worth understanding for both plaintiffs and defendants.
Explore precedents →With-prejudice dismissals with mutual cost-bearing strongly indicate private resolution; discovery of financial terms is unlikely absent SEC disclosure obligations.
View resolution trends →Frequently Asked Questions
The case involved U.S. Patent No. 11,857,482 (application no. US17/681367), covering percussive massage device technology.
The parties jointly requested dismissal after representing to the court that the matter had been resolved privately. The specific financial terms of any settlement or licensing agreement were not disclosed publicly, but a dismissal ‘with prejudice’ prevents Hyperice from re-filing the same infringement claims against Arboleaf for the same patent and accused products.
The case signals active enforcement of Hyperice’s patent portfolio in the percussive therapy market. Competitors should prioritize Freedom to Operate (FTO) analysis for new products and monitor Lead Case No. 2:24-cv-102, which remains open, for further developments regarding this patent family.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER (Public Access to Court Electronic Records) — Case 2:24-cv-00066
- U.S. Patent and Trademark Office — U.S. Patent No. 11,857,482
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.